Taiwan FDA registration e6dffd1c37854fbfddba7bcf62b836f5
"Le Pulse" Retius coaxial lead thrombus removal catheter
TW: “樂脈”雷緹斯同軸導線血栓清除導管
Taiwan·Risk Class 2·LEMAITRE VASCULAR, INC.·Registered Apr 03, 2009 – Apr 03, 2024ExpiredRegistration details
- Analysis ID
- e6dffd1c37854fbfddba7bcf62b836f5
- Customs Code
- DHA00601976400
Company information
- Manufacturer
- LEMAITRE VASCULAR, INC.
- Manufacturer Country
- United States
- Authorized Representative
- HSIN TUNG MEDICAL CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order.
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.5150 血栓切除術導管
- Import Information
- import
Dates and status
- Registration Date
- Apr 03, 2009
- Expiry Date
- Apr 03, 2024
About this record
Access comprehensive regulatory information for "Le Pulse" Retius coaxial lead thrombus removal catheter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e6dffd1c37854fbfddba7bcf62b836f5 and manufactured by LEMAITRE VASCULAR, INC.. The authorized representative in Taiwan is HSIN TUNG MEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices